ArticleILAR journal2022

Challenges and Opportunities in the Use of High and Maximum Biocontainment Facilities in Developing and Licensing Risk Group 3 and Risk Group 4 Agent Veterinary Vaccines.

David A Brake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.